Navigation Links
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
Date:6/9/2008

and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. Product candidates in Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with Endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza is available online at http://www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the potential timing of the announcement of results of the AZ-004 Phase 3 clinical trial, potential benefits of AZ-004, future development of the Company's product candidates and safety of the Company's products and technologies. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission including the risks under the headings: "Failure or delay in commencing or completing clinical trials for our product candidates could harm our business" and "If our product candidates do not meet safety and efficacy endpoints in clinical trials, they will not receive regulatory approval, and we will
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today ... ended December 31, 2014 on March 9, 2015. The Company also ... Thursday, March 12, 2015, at 5:00 pm ET. The call will ...   , , , LIVE CALL:  , ... 92238648. , , , , ...
(Date:3/1/2015)... , March 1, 2015  An innovative ... chronic migraine sufferers sustained relief of their headaches, ... Society of Interventional Radiology ,s Annual Scientific ... the State University New York Empire State College ... intranasal sphenopalatine ganglion (SPG) blocks to give patients ...
(Date:2/27/2015)... N.C. , Feb. 27, 2015 Pharmaceutical ... of managing multiple products for the same indication. This ... those that want to prevent one of their brands ... According to recent research by benchmarking firm, ... products as independent brands rather than together as part ...
Breaking Medicine Technology:ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2
... Lanx ® , Inc., a privately held medical ... for spinal surgery, today announced the launch of the ... Association of Neurological Surgeons (AANS) Annual Meeting, Denver, CO. ... invasive fixation alternative to pedicle screws, intended to stabilize ...
... 2011 Reportlinker.com announces that a new ... catalogue: Immuno Chemistry Reagents, ... Analysis, Competitive Landscape and Market Forecasts to ... Immuno Chemistry Reagents, Analyzers and ...
Cached Medicine Technology:Lanx®, Inc. Announces Launch of Concero™ Facet Screw System for Spinal Fusion 2Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12
(Date:3/2/2015)... (PRWEB) March 02, 2015 The Alliance ... fire safety expert Mark Chubb to serve as chief ... safety operations and training in Bangladesh and guide remediation ... , “Mark will ensure that the Alliance continues ... safety programs for Bangladesh garment workers,” said Alliance Independent ...
(Date:3/2/2015)... Secura Consultants announced today the launch ... Insurance Group of Birmingham, AL (First Protective). ... advisors to access the enhanced disability income marketing, ... , Secura Consultants, based in Minneapolis, ... and implementation of insured income protection programs. ...
(Date:3/1/2015)... Lake Orion, Metamora, Michigan (PRWEB) March 01, 2015 ... which is approved to treat Overactive Bladder (OAB) symptoms, such ... frequency in adults when another type of medication (anticholinergic) does ... is a different treatment option that takes another approach to ... , BOTOX® works on the nerves and bladder muscle, ...
(Date:3/1/2015)... 2015 Ticket Down is a reputable source ... at Soldier Field. Deadheads have been anxiously anticipating this ... Grateful Dead was formed 50 years ago back in the ... one until the untimely death of Jerry Garcia in 1995. ... including blues, reggae, rock, bluegrass, folk, space rock and country ...
(Date:3/1/2015)... 01, 2015 Theme and plugin developers ... transition pack for Final Cut Pro X entitled ... transitions to any FCPX editors project.” Said Christiana Austin, ... the tools needed to easily drag and drop their ... gets many different controls over the parameters of this ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2
... campaign on health and hygiene in violence-hit Afghanistaqn from Saturday. ... aims to educate more than two million people in the ... begin in Kabul on June 24, targeting 850,000 people, before ... ,Each phase lasts 20 days, and will involve hundreds ...
... recent study has revealed that the place of birth determines the ... lower life expectancy than those born in south east England //. ... was found to be 69.3 it was found to be 77 ... the research and it has ranked the 10 best and worst ...
... District Health Boards and Primary Health Organisations, (PHOs), which faced ... both parties reaching an agreement on the extension of ... who are GP patients, aged between 45 - 64 years, ... GPs have long been at loggerheads over the conditions, ...
... Wilson, elected to undergo hysterectomy and mastectomy. due to a ... family harbors to develop breast cancer //. Oonagh’s decision came ... least two more years for the results of the genetic ... changes in service delivery and delays in getting licenses from ...
... acting chief has expressed doubts as to whether the $46 ... a mental health rehabilitation unit in the Riverina. ... for the Wagga clubhouse itself has been stalled by the ... Heath Minister they commented that the Lands Minister had approved ...
... According to a study conducted by Yale university researchers it was ... one's life resulted in an increased rate of heart attacks //. ... to 61 years. The results of the study were published in ... suffered from heart attacks and strokes in about 10 years time ...
Cached Medicine News:Health News:Life Expectancy Determined by Place of Birth 2Health News:Woman Elects For Mastectomy: Prolonged Wait For Genetic Results 2Health News:Woman Elects For Mastectomy: Prolonged Wait For Genetic Results 3
... factor 1 (IGF-1) is a polypeptide of 70 ... a number of related insulin-like growth factors present ... sequence homology with proinsulin and has a number ... is growth hormone (GH) dependent to a high ...
...
...
...
Medicine Products: